Trial Listings
We are currently conducting one or more trials in the below listed indications, we are conducting both inpatient and outpatient trials in many indications.Child and Adolescent:
- ADHD (ages 6-12)
- Depression for Children 7-17
- Migraine Headaches 6-17
- Alzheimer’s Disease (ages 50-88)
- Schizophrenia Disorder (ages 18+)
- Women 18-50 with Depression and decreased sexual desire
Alzheimer’s Trial
Summary: Alliance Research Group is seeking individuals with Alzheimer’s disease.
All diagnostic and laboratory evaluations are done at no cost to the subject and study medication is provided at no charge. Transportation costs during study participation will be reimbursed.
For People With Alzheimer’s, There’s No Time to Lose
Alzheimer’s disease is a neurodegenerative disorder—a disorder in which brain cells are lost. It is characterized by progressive loss of memory and cognitive function, such as movement control and decision-making ability. Alzheimer’s disease is the most common cause of dementia in the elderly and affects about 18 million people worldwide—5 million in the U.S. alone. Although there’s currently no cure for Alzheimer’s disease, research is under way to find a new investigational treatment aimed at slowing the progression of the disease. The current medications are mostly aimed at maximizing the remaining brain activity. That’s why the ICARA study was created—to explore a new investigational treatment option.
If you are 50 to 88 years of age and have a diagnosis of probable Alzheimer’s disease, you may be eligible to participate in the ICARA study.
Throughout the 83-week study, participants may receive the investigational drug, study-related physical exams and laboratory services at no charge. All participants will be monitored by a medical team, including a nurse or study coordinator and a physician.
For more information visit, www.ICARAstudy.com
Migraine Headaches 6-17
Does your child experience migraine attacks?A clinical research study is being conducted to test the safety and effectiveness of an investigational study medication in treating symptoms of migraine attacks.
Your child may qualify for the Pediatric Migraine Study if he/she:<
- is between 6 and 17 years of age,
- has experienced migraine headaches for more than six months and,
- experiences between one and eight migraine headaches every month.
Contacting us for more information does not mean that your child is obligated to participate or that he/she will be eligible to participate.
<< Contact us about this trial
ADHD
A clinical research trial testing the safety and efficacy of an investigational non-stimulant ADHD medication when used in combination with a long lasting stimulant medication currently taken to treat ADHD.- Does your child have a diagnosis of ADHD?
- Is your child age 6-17?
- Does your child currently take a long acting stimulant to treat ADHD?
- Is your child still having trouble with ADHD symptoms?
- Are you and your child willing to consider adding a non-stimulant ADHD medication in combination with their current stimulant?
<< Contact us about this trial
Child and Adolescent
Childhood Depression is Often in HidingSummary: Alliance Research Group is Seeking Children & Adolescents Ages 7-17
Research is being done that may bring alternative treatment options into the open. If your child is depressed consider our research study.
Your child may be eligible to participate in this study if he/she:
- Is between the ages of 7 and 17, generally healthy
- Has been diagnosed with, or shows signs of depression
- Is able to swallow study medications whole without opening the capsule, crushing or dissolving
<< Contact us about this trial
Schizophrenia
Schizophrenia is a chronic, severe and debilitating brain disease that affects about 1% of the population worldwide. Symptoms generally begin in late adolescence or early adulthood. People with Schizophrenia often suffer symptoms such as hearing internal voices not heard by others, or believing that other people are reading their minds, controlling their thoughts, or plotting to harm them. Schizophrenia is associated with significant lifelong deficits in interpersonal relationships, the ability to work and the ability to care for oneself.Alliance Research Group is currently seeking participants to participate in a clinical research trial to help improve the lives of those who suffer from this disease.
Participants will be receive study medication and may also be compensated for their travel related expenses.